Steris (STE) Capital Expenditures Growth (3y) (2021 - 2026)
Analysis
Steris (STE) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -0.66% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -14.20% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 12.42% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 9.94% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 10.89% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 11.78% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.38% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 12.81% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 9.52% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -17.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.52% |
| Mar 31, 2026 | 8.08% |
| Dec 31, 2025 | 2.44% |
| Sep 30, 2025 | 1.48% |
| Jun 30, 2025 | -6.88% |
| Mar 31, 2025 | -1.00% |
| Dec 31, 2024 | 3.21% |
| Sep 30, 2024 | 9.80% |
| Jun 30, 2024 | 24.22% |
| Mar 31, 2024 | 6.95% |
| Dec 31, 2023 | 30.31% |
| Sep 30, 2023 | 23.81% |
| Jun 30, 2023 | -0.13% |
| Mar 31, 2023 | 5.49% |
| Dec 31, 2022 | 18.28% |
| Sep 30, 2022 | 19.61% |
| Jun 30, 2022 | 32.54% |
| Mar 31, 2022 | -1.51% |
| Dec 31, 2021 | 16.97% |
| Sep 30, 2021 | 30.26% |